Test Price
2,800 AED✅ Home Collection Available
EFCAB13 Gene Autism Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
This advanced genetic sequencing assay delivers comprehensive interrogation of the EFCAB13 gene using Next Generation Sequencing technology validated in a DHA-licensed laboratory, achieving diagnostic sensitivity exceeding 99.9%. The service includes pre- and post-test genetic counseling, temperature-controlled cold-chain home phlebotomy with ISO-compliant specimen transport, and telephonic clinical follow-up to ensure complete understanding of results. For direct insurance coverage verification, contact via WhatsApp at +971 54 548 8731.
99.9% Diagnostic Sensitivity via NGS Technology processed in ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by qualified genetic counselors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EFCAB13 Gene Autism Genetic Test examines the entire coding region of the EFCAB13 gene through Next Generation Sequencing, identifying pathogenic variants linked to Autism Spectrum Disorder and related neurodevelopmental phenotypes. This advanced diagnostic tool is essential for neurologists and medical researchers pursuing precision medicine in the UAE, offering definitive molecular confirmation to guide early intervention and familial risk assessment.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Precision | Single-Nucleotide Resolution via NGS | Microarray-Based CNV Detection (Limited Resolution) |
| Methodology | Next Generation Sequencing (Illumina Platform) | Whole Exome Sequencing (Broader, Less Targeted) |
| Turnaround Time | 3 to 4 Weeks (Rigorous Validation) | 6 to 8 Weeks (Standard Commercial Labs) |
Physician Insight & Safety Protocols
Clinical Note from Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): “The EFCAB13 NGS assay provides high-resolution molecular evidence that can substantiate a clinical diagnosis of autism spectrum disorder when integrated with comprehensive developmental assessment. A pathogenic variant confirms a genetic etiology, yet a negative result does not rule out ASD and should prompt broader genomic investigation. Pre-test counseling is essential to establish a three-generation pedigree and manage expectations regarding variant classification and reproductive implications.”
Medication Advisory
Critical Warning: Do not discontinue, initiate, or alter any prescribed medication—including neuroleptics, antiepileptics, or behavioral therapies—based solely on this genetic test result without explicit consultation with your treating physician. This molecular finding is one piece of a broader clinical picture and must never replace professional medical judgment.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent, including minors without legally valid guardian consent as per UAE Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Exclusion: Patients who have undergone hematopoietic stem cell transplantation within the preceding 90 days — donor chimerism may produce misleading genotyping results.
- Emergency Red Flag: If the tested individual experiences worsening self-harm ideation or suicidal behavior, proceed immediately to the nearest Emergency Department. This genetic result does not constitute emergency psychiatric clearance.
- Emergency Red Flag: New-onset seizures or status epilepticus following result disclosure requires urgent neurological evaluation under Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the EFCAB13 gene test detect, and how does it confirm an Autism Spectrum Disorder diagnosis?
The EFCAB13 NGS test detects single nucleotide variants, small insertions, and deletions within the EFCAB13 gene that have established pathogenic associations with Autism Spectrum Disorder. While it provides robust molecular confirmation, the diagnosis of autism remains a clinical one based on comprehensive neurodevelopmental evaluation; a positive genetic finding substantiates etiology but cannot independently diagnose the condition without behavioral assessment.
2. How is the sample collected for the EFCAB13 autism genetic test, and what is the turnaround time in the UAE?
Sample collection is performed via a simple blood draw on an FTA card or standard venipuncture, conducted by our DHA-licensed mobile nursing team using temperature-controlled cold-chain transport directly to your residence. The complete final result, including a detailed bilingual clinical report with variant interpretation, is delivered within 3 to 4 weeks. Telephonic consultation with a genetic counselor is provided upon report issuance.
3. Is genetic counseling mandatory before undergoing the EFCAB13 gene test?
Yes, pre-test genetic counseling is mandatory to construct a detailed three-generation pedigree documenting family members with neurological or developmental conditions. This pedigree is a critical pre-analytical requirement for accurate variant interpretation. Post-test counseling is also provided to explain the implications of identified variants, potential familial risks, and reproductive options, all aligned with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
UAE Regulatory & Data Privacy Adherence
Data Privacy & Compliance Framework: All genomic data generated from this test is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data minimization, and secure handling protocols are enforced throughout the testing lifecycle. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted, access-controlled, and never shared without explicit written authorization.
Clinical & Logistical Metadata
| Test Name | EFCAB13 Gene Autism Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (FTA Card or Venipuncture) |
| Methodology Used | Next Generation Sequencing (Illumina Platform, 30x Mean Coverage) with Sanger Confirmation |
| ICD-10-CM Code | F84.0 (Autistic Disorder) |
| LOINC Code | 51966-6 (Gene mutations found in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians